1 |
Bas a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell, 19, 629-39.
|
2 |
Berdougo E, Nachury MV, Jackson PK, Jallepalli PV (2008). The nucleolar phosphatase Cdc14B is dispensable for chromosome segregation and mitotic exit in human cells. Cell Cycle, 7, 1184-90.
DOI
|
3 |
Beuming T, Skrabanek L, Niv MY, Mukherjee P, Weinstein H (2005). PDZBase: a protein-protein interaction database for PDZ-domains. Bioinformatics, 21, 827-28.
DOI
ScienceOn
|
4 |
Bremmer SC, Hall H, Martinez JS, et al (2012). Cdc14 phosphatases preferentially dephosphorylate a subset of cyclin-dependent kinase (Cdk) sites containing phosphoserine. J Biol Chem, 287, 1662-9.
DOI
|
5 |
Chan KS, Koh CG, Li HY (2012). Mitosis-targeted anti-cancer therapies: where they stand. Cell Death Dis, 3, 411.
DOI
ScienceOn
|
6 |
Chen J, Chan AW, To KF, et al (2013). SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-/-catenin signaling. Hepatology, 57, 2287-98.
DOI
ScienceOn
|
7 |
Chiesa M, Guillamot M, Bueno MJ, Malumbres M (2011). The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway. Cell Cycle, 10, 1607-17.
DOI
|
8 |
Cho HP, Liu Y, Gomez M, et al (2005). The dual-specificity phosphatase CDC14B bundles and stabilizes microtubules. Mol Cell Biol, 25, 4541-51.
DOI
ScienceOn
|
9 |
Dinkel H, Michael S, Weatheritt RJ, et al (2012). ELM--the database of eukaryotic linear motifs. Nucleic Acids Res, 40, 242-51.
|
10 |
Dryden SC, Nahhas FA, Nowak JE, Goustin AS, Tainsky MA (2003). Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol, 23, 3173-85.
DOI
ScienceOn
|
11 |
Galeano F, Rossetti C, Tomaselli S, et al (2013). ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis. Oncogene, 32, 998-1009.
DOI
ScienceOn
|
12 |
Galan-Malo P, Vela L, Gonzalo O, et al (2012). Cell fate after mitotic arrest in different tumor cells is determined by the balance between slippage and apoptotic threshold. Toxicol Appl Pharmacol, 258, 384-93.
DOI
ScienceOn
|
13 |
Gascoigne KE, Cheeseman IM (2013). CDK-dependent phosphorylation and nuclear exclusion coordinately control kinetochore assembly state. J Cell Biol, 201, 23-32.
DOI
ScienceOn
|
14 |
Gascoigne KE, Taylor SS (2008). Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell, 14, 111-22.
DOI
ScienceOn
|
15 |
Graham JM (2002). Preparation of crude subcellular fractions by differential centrifugation. Sci World J, 2, 1638-42.
DOI
|
16 |
Hancioglu B, Tyson JJ (2012). A mathematical model of mitotic exit in budding yeast: the role of Polo kinase. PLoS One, 7, 308-10.
|
17 |
Huang HC, Shi J, Orth JD, Mitchison TJ (2009). Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell, 16, 347-58.
DOI
ScienceOn
|
18 |
Lai CC, Lin PM, Lin SF, et al (2013). Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol, 34, 1847-54.
DOI
ScienceOn
|
19 |
Hunt T (2013). On the regulation of protein phosphatase 2A and its role in controlling entry into and exit from mitosis. Adv Biol Regul, 53, 173-8.
DOI
ScienceOn
|
20 |
Janssen A, Medema RH (2011). Mitosis as an anti-cancer target. Oncogene, 30, 2799-809.
DOI
ScienceOn
|
21 |
Larkin MA, Blackshields G, Brown NP, et al. (2007). Clustal W and Clustal X version 2.0. Bioinformatics, 23, 2947-48.
DOI
ScienceOn
|
22 |
Lupas A, Van Dyke M, Stock, J. (1991). Predicting coiled coils from protein sequences. Science, 252, 1162-64.
DOI
|
23 |
Manchado E, Guillamot M, de Carcer G, et al (2010). Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/, phosphatase. Cancer Cell, 18, 641-54.
DOI
ScienceOn
|
24 |
Massey AJ, Borgognoni J, Bentley C (2010). Context-dependent cell cycle checkpoint abrogation by a novel kinase inhibitor. PLoS One, 5, 13123.
DOI
ScienceOn
|
25 |
Maya-Mendoza A, Jackson, DA (2009). Replication timing: findings from fibers. Cell Cycle, 8, 3073-74.
|
26 |
Mocciaro A, Berdougo E, Zeng K (2010). Vertebrate cells genetically deficient for Cdc14A or Cdc14B retain DNA damage checkpoint proficiency but are impaired in DNA repair. J Cell Biol, 189, 631-9.
DOI
ScienceOn
|
27 |
Mocciaro A, Schiebel E. (2010). Cdc14: a highly conserved family of phosphatases with non-conserved functions? J Cell Sci, 123, 2867-76.
DOI
ScienceOn
|
28 |
Mochida S, Hunt T (2007). Calcineurin is required to release Xenopus egg extracts from meiotic M phase. Nature, 449, 336-40.
DOI
ScienceOn
|
29 |
Nalepa G, Harper JW (2004). Visualization of a highly organized intranuclear network of filaments in living mammalian cells. Cell Motil Cytoskeleton, 59, 94-108.
DOI
ScienceOn
|
30 |
Mendez J, Stillman B (2000). Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol Cell Biol, 20, 8602-12.
DOI
|
31 |
Naruyama H, Shimada M, Niida H, et al (2008). Essential role of Chk1 in S phase progression through regulation of RNR2 expression. Biochem Biophys Res Commun, 374, 79-83.
DOI
ScienceOn
|
32 |
Niida H, Katsuno Y, Banerjee B, Hande MP, Nakanishi M (2007). Specific role of Chk1 phosphorylations in cell survival and checkpoint activation. Mol Cell Biol, 27, 2572-81.
DOI
ScienceOn
|
33 |
North BJ, Verdin E (2007). Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation. J Biol Chem, 282, 19546-55.
DOI
ScienceOn
|
34 |
Novak B, Tyson JJ, Gyorffy B, Csikasz-Nagy A (2007). Irreversible cell-cycle transitions are due to systems-level feedback. Nat Cell Biol, 9, 724-28.
DOI
ScienceOn
|
35 |
Patterson KI, Brummer T, O'Brien PM, Daly RJ (2009). Dualspecificity phosphatases: critical regulators with diverse cellular targets. Biochem J, 418, 475-89.
|
36 |
Rossio V, Galati E, Ferrari M, et al (2010). The RSC chromatinremodeling complex influences mitotic exit and adaptation to the spindle assembly checkpoint by controlling the Cdc14 phosphatase. J Cell Biol, 191, 981-97.
DOI
ScienceOn
|
37 |
Russell P, Hennessy BT, Li J, et al (2012). Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest. Oncogene, 31, 2450-60.
DOI
ScienceOn
|
38 |
Shimada M, Niida H, Zineldeen DH, et al (2008). Chk1 is a histone H3 threonine 11 kinase that regulates DNA damageinduced transcriptional repression. Cell, 132, 221-32.
DOI
ScienceOn
|
39 |
Sanchez-Diaz A, Nkosi PJ, Murray S, Labib K (2012). The Mitotic Exit Network and Cdc14 phosphatase initiate cytokinesis by counteracting CDK phosphorylations and blocking polarised growth. EMBO J, 31, 3620-34.
DOI
|
40 |
Shimada M, Nakanishi M (2013). Response to DNA damage: why do we need to focus on protein phosphatases? Front Oncol, 3, 8.
|
41 |
Skoufias DA, Indorato RL, Lacroix F, Panopoulos A, Margolis RL (2007). Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed. J Cell Biol, 179, 671-85.
DOI
ScienceOn
|
42 |
Takeo S, Hawley RS, Aigaki T (2010). Calcineurin and its regulation by Sra/RCAN is required for completion of meiosis in Drosophila. Dev Biol, 344, 957-67.
DOI
ScienceOn
|
43 |
Theobald B, Bonness K, Musiyenko A (2013). Suppression of ser/thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell death. Mol Cancer Res, [Epub ahead of print].
|
44 |
Uchida T, Matozaki T, Matsuda K (1993). Phorbol ester stimulates the activity of a protein tyrosine phosphatase containing SH2 domains (PTP1C) in HL-60 leukemia cells by increasing gene expression. J Biol Chem, 268, 11845-50.
|
45 |
van den Berk LC, Landi E, Harmsen E, Dente L, Hendriks WJ (2005). Redox-regulated affinity of the third PDZ domain in the phosphotyrosine phosphatase PTP-BL for cysteinecontaining target peptides. FEBS J, 272, 3306-16.
DOI
ScienceOn
|
46 |
Visconti R, Palazzo L, Della Monica R, Grieco D (2012). Fcp1-dependent dephosphorylation is required for M-phasepromoting factor inactivation at mitosis exit. Nat Commun, 3, 894.
DOI
ScienceOn
|
47 |
Wurzenberger C, Gerlich DW (2011). Phosphatases: providing safe passage through mitotic exit. Nat Rev Mol Cell Biol, 12, 469-82.
DOI
ScienceOn
|
48 |
Vazquez-Novelle MD, Esteban V, Bueno A, Sacristan MP. (2005). Functional homology among human and fission yeast Cdc14 phosphatases. J Biol Chem, 280, 29144-50.
DOI
ScienceOn
|
49 |
Wei Z, Zhang P (2011). A phosphatase turns aggressive: the oncogenicity of Cdc14B. Cell Cycle, 10, 2414.
DOI
|
50 |
Wu J, Cho HP, Rhee DB, et al (2008). Cdc14B depletion leads to centriole amplification, and its overexpression prevents unscheduled centriole duplication. J Cell Biol, 181, 475-83.
DOI
ScienceOn
|
51 |
Zhang Q, Claret FX (2012). Phosphatases: the new brakes for cancer development? Enzyme Res, 2012, 659649.
|
52 |
Zineldeen DH, Shimada M, Niida H, Katsuno Y, Nakanishi M (2009). Ptpcd-1 is a novel cell cycle related phosphatase that regulates centriole duplication and cytokinesis. Biochem Biophys Res Commun, 380, 460-6.
DOI
ScienceOn
|